ENDPOINTS

Sarepta’s stock plummets after Prasad appointment, low Elevidys sales

Sarepta Therapeutics had a bad day in Washington. And then a worse one on Wall Street. On Tuesday, the company's stock fell 27% following the news that Vinay Prasad would be the new head of ...

May 7, 2025 - 02:30
 0
Sarepta’s stock plummets after Prasad appointment, low Elevidys sales
Sarepta Therapeutics had a bad day in Washington. And then a worse one on Wall Street. On Tuesday, the company's stock fell 27% following the news that Vinay Prasad would be the new head of ...
Read More

Tags:

Previous Article

Successful urban birds sport different colours from unsuccessful ones

Next Article

ŌURA Launches AI-Powered “Meals” & “Glucose” Tracking for Enhanced Metabolic Health

Related Posts

Paul Stoffels on retiring from Galapagos; Boehringer Ingelheim switches up leadership

Paul Stoffels on retiring from Galapagos; Boehringer In...

Apr 25, 2025  0

AstraZeneca rejoins PhRMA, two years after leaving lobby group

AstraZeneca rejoins PhRMA, two years after leaving lobb...

Apr 22, 2025  0

Bristol Myers Q1 earnings: Transition continues as drugmaker raises guidance

Bristol Myers Q1 earnings: Transition continues as drug...

Apr 24, 2025  0